Phase II study of cytembena (NSC-104801) in advanced colorectal carcinoma.
D000179:Acrylates / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002319:Cardiovascular System / Q000187:drug effects; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012004:Rectal Neoplasms / Q000188:drug therapy*
D000179:Acrylates